Predicting Sepsis in Heart Failure Patients Supported by Left Ventricular Assist Devices: The Role of VE-Cadherin and ADAM10
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27020563 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shiyi Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Cadherins, ADAM10 Protein, Heart-Assist Devices, Heart Failure. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baylor College of Medicine.
Themen: Herzinsuffizienz, Sepsis
Abstract (Originalsprache)
Vascular endothelial cadherin (VE-Cadherin) is a major endothelial adhesion molecule and can be cleaved explicitly by metalloproteinase domain-containing protein 10 (ADAM10). Vascular hyperpermeability may contribute to a greater susceptibility to sepsis in left ventricular assist device (LVAD) support patients. We aim to evaluate the efficacy of VE-Cadherin and ADAM10 for predicting sepsis in LVAD patients. We prospectively recruited 50 patients with advanced heart failure receiving LVAD therapy. Baseline and weekly postoperative blood samples (weeks 1–4) were collected, and plasma VE-cadherin and ADAM10 levels were measured. Sepsis occurred in 9 of 50 patients (18.0%). Across all sampling points, plasma VE-cadherin and ADAM10 levels were significantly higher in the sepsis group relative to the non-sepsis group. From pre-implantation to 1-week and 1-month post-operation, VE-Cadherin alone showed good performance for sepsis prediction, with areas under the receiver operating characteristic (AUC) of 0.75, 0.81, 0.69, 0.72, and 0.77, respectively. A significant positive correlation between VE-cadherin and ADAM10 was detected only among sepsis patients. Incorporating ADAM10 into the prediction models significantly enhances their predictive performance. Plasma VE-Cadherin levels can be a valuable biomarker for predicting sepsis in LVAD patients, with predictive performance further enhanced when combined with circulating ADAM10 levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.
- Michael E. DeBakey Department of Surgery, Division of Cardiothoracic Transplantation and Circulatory Support, Baylor College of Medicine, Houston, TX 77030, USA.
- Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Regenerative Medicine Research, Texas Heart Institute, Houston, TX 77030, USA.
ORCID-Profile: Shiyi Li, Rishav Bhattacharya, Shreyo Ghosh, Camila Hochman-Mendez, Nandan K Mondal
Förderung
- Baylor College of Medicine
Zitieren
APA
Li, S., Murrieta-Álvarez, I., Garcia, I., Nordick, K. V., Bhattacharya, R., Ghosh, S., Shaju, R. A., Hassan, A. M., Walther, C. P., Hochman-Mendez, C., Shafii, A. E., Liao, K. K., & Mondal, N. K. (2026). Predicting Sepsis in Heart Failure Patients Supported by Left Ventricular Assist Devices: The Role of VE-Cadherin and ADAM10. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020563
Vancouver
Li S, Murrieta-Álvarez I, Garcia I, Nordick KV, Bhattacharya R, Ghosh S, et al. Predicting Sepsis in Heart Failure Patients Supported by Left Ventricular Assist Devices: The Role of VE-Cadherin and ADAM10. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020563
BibTeX
@article{Li2026,
author = {Li, Shiyi and Murrieta-Álvarez, Iván and Garcia, Ismael and Nordick, Katherine V and Bhattacharya, Rishav and Ghosh, Shreyo and Shaju, Ronald A and Hassan, Adel M and Walther, Carl P and Hochman-Mendez, Camila and Shafii, Alexis E and Liao, Kenneth K and Mondal, Nandan K},
title = {Predicting Sepsis in Heart Failure Patients Supported by Left Ventricular Assist Devices: The Role of VE-Cadherin and ADAM10},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27020563}
}
EUVIMED